Literature DB >> 16023668

Crystal structures of Escherichia coli KDO8P synthase complexes reveal the source of catalytic irreversibility.

Radion Vainer1, Valery Belakhov, Emilia Rabkin, Timor Baasov, Noam Adir.   

Abstract

The enzyme 3-deoxy-D-manno-2-octulosonate-8-phosphate synthase (KDO8PS) catalyses the condensation of arabinose 5-phosphate (A5P) and phosphoenol pyruvate (PEP) to obtain 3-deoxy-D-manno-2-octulosonate-8-phosphate (KDO8P). We have elucidated initial modes of ligand binding in KDO8PS binary complexes by X-ray crystallography. Structures of the apo-enzyme and of binary complexes with the substrate PEP, the product KDO8P and the catalytically inactive 1-deoxy analog of arabinose 5-phosphate (1dA5P) were obtained. The KDO8PS active site resembles an irregular funnel with positive electrostatic potential situated at the bottom of the PEP-binding sub-site, which is the primary attractive force towards negatively charged phosphate moieties of all ligands. The structures of the ligand-free apo-KDO8PS and the binary complex with the product KDO8P visualize for the first time the role of His202 as an active-site gate. Examination of the crystal structures of KDO8PS with the KDO8P or 1dA5P shows these ligands bound to the enzyme in the PEP-binding sub-site, and not as expected to the A5P sub-site. Taken together, the structures presented here strengthen earlier evidence that this enzyme functions predominantly through positional catalysis, map out the roles of active-site residues and provide evidence that explains the total lack of catalytic reversibility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023668     DOI: 10.1016/j.jmb.2005.06.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  2 in total

1.  Segmented flow generator for serial crystallography at the European X-ray free electron laser.

Authors:  Austin Echelmeier; Jorvani Cruz Villarreal; Marc Messerschmidt; Daihyun Kim; Jesse D Coe; Darren Thifault; Sabine Botha; Ana Egatz-Gomez; Sahir Gandhi; Gerrit Brehm; Chelsie E Conrad; Debra T Hansen; Caleb Madsen; Saša Bajt; J Domingo Meza-Aguilar; Dominik Oberthür; Max O Wiedorn; Holger Fleckenstein; Derek Mendez; Juraj Knoška; Jose M Martin-Garcia; Hao Hu; Stella Lisova; Aschkan Allahgholi; Yaroslav Gevorkov; Kartik Ayyer; Steve Aplin; Helen Mary Ginn; Heinz Graafsma; Andrew J Morgan; Dominic Greiffenberg; Alexander Klujev; Torsten Laurus; Jennifer Poehlsen; Ulrich Trunk; Davide Mezza; Bernd Schmidt; Manuela Kuhn; Raimund Fromme; Jolanta Sztuk-Dambietz; Natascha Raab; Steffen Hauf; Alessandro Silenzi; Thomas Michelat; Chen Xu; Cyril Danilevski; Andrea Parenti; Leonce Mekinda; Britta Weinhausen; Grant Mills; Patrik Vagovic; Yoonhee Kim; Henry Kirkwood; Richard Bean; Johan Bielecki; Stephan Stern; Klaus Giewekemeyer; Adam R Round; Joachim Schulz; Katerina Dörner; Thomas D Grant; Valerio Mariani; Anton Barty; Adrian P Mancuso; Uwe Weierstall; John C H Spence; Henry N Chapman; Nadia Zatsepin; Petra Fromme; Richard A Kirian; Alexandra Ros
Journal:  Nat Commun       Date:  2020-09-09       Impact factor: 14.919

Review 2.  Advances in UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Covalent Inhibition.

Authors:  Maycon Vinicius Damasceno de Oliveira; Renan Machado Furtado; Kauê S da Costa; Serhii Vakal; Anderson H Lima
Journal:  Front Mol Biosci       Date:  2022-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.